Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-05-18 @ 2:01 PM
Study NCT ID:
NCT01236404
Status:
COMPLETED
Last Update Posted:
2013-05-21
First Post:
2010-11-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus
Sponsor:
PhaseBio Pharmaceuticals Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PB1023-PT-CL-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None